Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REAGIR II: Rose Bengal Photodynamic Therapy for Bacterial Keratitis
NCT06271772Phase 3Active, not recruiting
- Sponsor
- University of California, San Francisco
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of rose bengal in bacterial keratitis, sponsored by University of California, San Francisco. Started Jul 2024; status: active, not recruiting.
02
Drugs
rose bengal
03
Conditions
bacterial keratitis
Beyond the preview
Go deeper on NCT06271772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06271772.